All our readers and authors enjoy the benefits of free open access. We believe that open access of the journal promotes accessibility and uptake worldwide, serving the best interests of the professional and scientific community and the public at large. Since no fees are charged for access, Pharmacophore offsets the publication expenses – including those of peer review management, journal production and online hosting and archiving – by charging Article Processing Charges (APC), also known as page fees, to authors, institutions or funders for each article published.
The APC for this journal is 10,000 INR for Indian authors and 675 US Dollars for international authors (excl. VAT) per A4 output page in PDF format. The average length of an article in this journal is 9 pages.
This APC is valid for the current calendar year and may be changed at any time at the sole discretion of the publisher.
The submitting author is responsible for payment of the APC and must confirm, at the time of submission, that s/he will organize payment of the APC, should the article be accepted for publication. This responsibility may not be delegated to any third party unless agreed to by the publisher.
ASC does not apply.
Authors will be given the opportunity to revise and approve the text of the accepted manuscript in the final phase of copy-editing. After author approval the manuscript will go to design layout. The author will be asked to proofread the final galleys before going to publishing. Proofreading is intended to correct typesetting mistakes and not to introduce new changes to the text; such changes will require new layout of the pages. If new changes are introduced at this final proofreading stage, the publisher will charge Galley Change Fees (GCF) to the author, based on the cost incurred to make such changes.
The GCF per hour is 600 INR [excluding VAT].
The final APC is derived from an estimated A4 PDF page count, based on the finally approved manuscript word count, and no changes will be made after invoicing.
Only one invoice shall be issued per article (no splitting of invoices) in order to expedite publication and keep costs to a minimum. All amounts are due within 30 days from invoicing. Payment can be made by Credit Card and Electronic Funds Transfer (EFT). The article will only be published once full payment has been received. the author will be responsible for any bank transfer charges at the time of the transaction. In all cases a receipt will be sent by email once payment has been received.
Authors are encouraged to contact their institution, funder or the Editor-in-Chief of the journal for more details of possible APC subsidy opportunities. Possibilities are: covering APC in the research grant, utilizing the open access funds of the institution, or a direct APC waiver by the publisher.
Pharmacophore complies with the requirements of funding bodies such as the Welcome Trust and the National Research Foundation, to help authors comply with their open access terms.
Authors may apply to Pharmacophore for waiving of the APC, which may be granted at the sole discretion of Pharmacophore /the funder. In order to be fair to all authors, a full waiver of the APC is only granted under exceptional circumstances.
To consider your APC waiver request we need the following:
The journal adheres to our publication fee policy, which includes our reimbursement policy.